Dusty canned food labeled CAG in a dark pantry with a faint rising stock chart in the background symbolizing a deep value investment opportunity

Conagra (CAG): 9% Yield Bargain or Value Trap? 🥫📉

Conagra (CAG) is down big, insiders are buying, and the dividend is near 9%. Is this a deep-value opportunity—or a trap in disguise? 🥫

Read entire article

A stylized financial illustration showing executives and insiders placing large stock buy orders in front of a glowing market scoreboard featuring companies like OSCR, NKE, and LW, symbolizing major insider buying activity.

📈 Top 10 Insider Buys April 2026: CEOs Buying OSCR, NKE, LW & More

CEOs, directors, and 10% owners are writing real checks again. From Oscar Health’s massive $11.9M buy to Nike’s continued dip-buying, here are the most interesting insider moves of April 2026.

Read entire article

Illustration of a worn sneaker representing Nike stock decline transitioning into a glowing running shoe symbolizing a potential turnaround, with a rising stock chart and investors buying at the bottom.

Nike (NKE) Stock: Insiders Keep Buying the Dip—Should You? 👟

Nike (NKE) has fallen sharply from its highs, but insider buying, strong brand equity, and improved valuation are turning heads. Is this the start of a comeback—or a trap?

Read entire article

A cinematic boardroom scene with glowing stock tickers like MGM, PANW, AHCO, and CPNG on large screens, executives reviewing insider purchase filings, symbolizing high-conviction insider buying in April 2026.

Top 10 Insider Buys April 2026: Where CEOs Are Investing Millions Now 📈

When CEOs, directors, and 10% owners buy millions of dollars of their own stock, it’s worth paying attention. Here are the top insider buys of April 2026—and why MGM, PANW, AHCO, and others stand out.

 

Read entire article

Digital healthcare check-in kiosks in a modern clinic with a falling stock chart in the background and an investor buying during the dip, symbolizing Phreesia’s market selloff and insider confidence.

Phreesia (PHR): Profitable… Then Crushed — Why Insiders Are Loading Up

Phreesia just hit profitability—and got punished for it. With insiders loading up and institutions fully committed, is this a classic overreaction or a value trap? Let’s decode the dip.

Read entire article

Split image showing Corcept Therapeutics stock volatility: one side with a red falling chart and FDA rejection stamp, the other with a green rising chart and glowing biotech lab vial, symbolizing high-risk, high-reward biotech investing.

CORT Stock 2026: FDA Rejection, Insider Buying… and a Brewing Short Squeeze?

Corcept Therapeutics just got hit with an FDA rejection—but insiders are buying millions and short interest is surging. With a profitable base business and major 2026 catalysts ahead, CORT may be one of the most explosive “binary bets” in biotech today.

Read entire article

Illustration of a ski mountain shaped like a falling stock chart with a skier buying shares while bears chase and a crowded lift labeled institutional ownership, symbolizing Vail Resorts stock dynamics.

MTN Stock Analysis 2026: Why Rob Katz’s $5M Buy Signals a Peak Opportunity in Vail Resorts

Vail Resorts (MTN) just endured one of the worst snowfall seasons in decades—yet insiders are buying millions in stock. With a powerful Epic Pass model, heavy institutional ownership, and rising short interest, this mountain stock may be setting up for a contrarian move.

Read entire article

Illustration of a large rock foundation supporting houses, greenhouses, and bridges while a construction worker labeled “OmniMax” installs a steel beam, symbolizing Gibraltar Industries’ role in residential, agtech, and infrastructure markets.

ROCK Stock Analysis 2026: Is Gibraltar Industries Undervalued by 71% After the OmniMax Deal?

Gibraltar Industries may not be glamorous, but the company sits at the heart of housing, infrastructure, and agtech. With insider buying, a massive OmniMax acquisition, and valuations near historic lows, ROCK could be one of the market’s most overlooked industrial value plays.

Read entire article

Illustration of a fox sitting on a pile of FOX stock certificates and TV screens broadcasting live sports, while institutional investors crowd around a small door labeled “float,” symbolizing limited available shares and potential market squeeze.

FOX Stock Analysis 2026: Lachlan Murdoch’s $10M Buy and the Hidden Institutional Squeeze

When FOX’s CEO Lachlan Murdoch bought $10 million of his own stock, Wall Street barely blinked. But with institutions owning 109% of the float and live sports dominating advertising markets, FOX might be setting up for one of the most overlooked media squeezes of the decade.

Read entire article

Illustration of a luxury handbag on a fashion runway with stock charts and price tags around it, symbolizing Capri Holdings (CPRI) stock as a potential turnaround investment after the Versace sale.

CPRI Stock Analysis 2026: Is Capri Holdings a Post-Versace Value Gem or a Fashion Victim?

Capri Holdings sold Versace, cleaned up its balance sheet, and now trades near multi-year lows. With insider buying and heavy institutional ownership, investors face a classic question: is CPRI a luxury turnaround or a fading fashion house?

Read entire article